Project Details
about the project
LinusBio is a biotech company that analyzes hair to reveal health and exposure information. Their technology detects diseases and environmental factors through a non-invasive test, with early applications focused on detecting autism in children.
Details
Client
LinusBio
Category
Health Tech
Service
Communication Strategy
Our Work
The Challenge
Although LinusBio had raised new funding, its technology had not yet received FDA approval. We needed to communicate the groundbreaking potential of the platform while addressing media skepticism and disinformation around autism detection.
Our Approach
Rather than position the announcement as a standard funding story, we reframed it as a scientific breakthrough. We focused outreach on science and health reporters who could credibly cover the technology and its implications.
The Results
- Secured 18 media placements across major national, business, healthcare, and local outlets, including NBC News, The New York Post, Daily Mail, Yahoo! Finance, and Fierce Biotech.
- Coverage reached an estimated 100M+ monthly unique visitors.
- NBC News conducted an in-depth report, interviewing six independent experts to validate LinusBio’s proprietary method for tracking metal metabolism in hair samples.
No items found.
No items found.
Ready for real results?
